Cerus Corp (CERS)
1.70
0.00 (0.00%)
USD |
NASDAQ |
Apr 26, 10:03
Cerus Cash from Financing (TTM): 10.67M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 10.67M |
September 30, 2023 | 9.947M |
June 30, 2023 | 3.429M |
March 31, 2023 | 3.804M |
December 31, 2022 | 4.192M |
September 30, 2022 | 15.83M |
June 30, 2022 | 19.33M |
March 31, 2022 | 19.26M |
December 31, 2021 | 34.29M |
September 30, 2021 | 30.48M |
June 30, 2021 | 30.07M |
March 31, 2021 | 40.59M |
December 31, 2020 | 91.78M |
September 30, 2020 | 92.98M |
June 30, 2020 | 101.88M |
March 31, 2020 | 103.04M |
December 31, 2019 | 43.49M |
September 30, 2019 | 40.40M |
June 30, 2019 | 39.72M |
March 31, 2019 | 43.06M |
December 31, 2018 | 92.75M |
September 30, 2018 | 97.68M |
June 30, 2018 | 107.20M |
March 31, 2018 | 102.71M |
December 31, 2017 | 43.00M |
Date | Value |
---|---|
September 30, 2017 | 31.97M |
June 30, 2017 | 18.94M |
March 31, 2017 | 15.82M |
December 31, 2016 | 24.57M |
September 30, 2016 | 30.37M |
June 30, 2016 | 22.61M |
March 31, 2016 | 29.32M |
December 31, 2015 | 97.95M |
September 30, 2015 | 104.78M |
June 30, 2015 | 114.06M |
March 31, 2015 | 111.62M |
December 31, 2014 | 36.45M |
September 30, 2014 | 34.76M |
June 30, 2014 | 26.04M |
March 31, 2014 | 9.129M |
December 31, 2013 | 58.64M |
September 30, 2013 | 50.30M |
June 30, 2013 | 50.42M |
March 31, 2013 | 56.10M |
December 31, 2012 | 14.91M |
September 30, 2012 | 23.56M |
June 30, 2012 | 22.78M |
March 31, 2012 | 21.73M |
December 31, 2011 | 11.62M |
September 30, 2011 | 20.92M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
3.429M
Minimum
Jun 2023
103.04M
Maximum
Mar 2020
38.69M
Average
30.48M
Median
Sep 2021
Cash from Financing (TTM) Benchmarks
AVITA Medical Inc | 40.37M |
Elutia Inc | 9.84M |
Perspective Therapeutics Inc | 0.785M |
Xtant Medical Holdings Inc | 19.69M |
Asensus Surgical Inc | 9.626M |